| Authors: |
Packer M; Baylor Heart and Vascular Institute, Dallas, TX (M.P.).; Imperial College, London, UK (M.P.)., Schiattarella GG; Max Rubner Center for Cardiovascular Metabolic Renal Research (MRC), Deutsches Herzzentrum der Charité (DHZC), Charité-Universitätsmedizin Berlin, Germany (G.G.S.).; Division of Cardiology, Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy (G.G.S.)., Petrie MC; School of Cardiovascular and Metabolic Health, University of Glasgow, UK (M.C.P.)., Burkhoff D; Cardiovascular Research Foundation, New York, NY (D.B.)., Butler J; Baylor Scott & White Research Institute, Dallas, TX (J.B.).; University of Mississippi School of Medicine, Jackson (J.B.)., Lam CSP; Cardiovascular and Metabolic Disorders Programme, Duke-National University of Singapore Medical School (C.S.P.L.).; National Heart Centre Singapore (C.S.P.L.)., Zannad F; Université de Lorraine, Centres d'Investigation Clinique, INSERM, Centre Hospitalier Régional Universitaire de Nancy, France (F.Z.)., Vaduganathan M; Division of Cardiovascular Medicine Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.V.)., Borlaug BA; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (B.A.B.). |
